Common Contracts
3 similar Securities Purchase Agreement contracts by Cue Biopharma, Inc., Provention Bio, Inc.
PROVENTION BIO, INC. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 9th, 2018 • Provention Bio, Inc. • Pharmaceutical preparations • Delaware
This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of April 25, 2017, is made and entered into by and between PROVENTION BIO, INC., a Delaware corporation with its principal executive offices located at 110 Old Driftway Lane, Lebanon, NJ 08833 (the “Company”), and each of the purchasers listed on Schedule A hereto (the “Purchasers”).
Cue Biopharma, Inc. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 21st, 2017 • Cue Biopharma, Inc. • Delaware
This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of December ___, 2016, is made and entered into by and between Cue Biopharma, Inc., a Delaware corporation (formerly Imagen Biopharma, Inc.) with its principal executive offices located at 675 W. Kendall St., Cambridge, MA 02142 (the “Company”), and each of the purchasers listed on Schedule A hereto (the “Purchasers”).
Imagen Biopharma, Inc. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 21st, 2017 • Cue Biopharma, Inc. • California
This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of June 15, 2015, is made and entered into by and between Imagen Biopharma, Inc., a Delaware corporation with its principal executive offices located at 401 Wilshire Boulevard, Suite 1020 Santa Monica, CA 90401 (the “Company”), and each of the purchasers listed on Schedule A hereto (the “Purchasers”).
